Sonnet BioTherapeutics HoldingsSONN 
$1.812.26%24h
2.26%24h
Global rank32501
Market cap$1.88M
Change 7d-58.29%
YTD Performance4.02%
SP500 benchmarkUnderperform
P/E-0.10
P/S12.71
Revenue$147.81K
Earnings-$18.83M
Dividend yield-
Main Sector
Healthcare
Sonnet BioTherapeutics Holdings (SONN) Cash on Hand
SONN Cash on Hand in 2022: $2.27M
According to Sonnet BioTherapeutics Holdings latest financial reports the cash on hand of SONN is $2.27M, an decrease of -25.50% to 2022. At the end of 2022 company had $3.05M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
SONN Cash on Hand History from 2019 to 2023
-
Value:-
SONN Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $2.27M | -25.50% |
| 2022 | $3.05M | -88.95% |
| 2021 | $27.62M | 275.82% |
| 2020 | $7.35M | 20515.10% |
| 2019 | $35.65K | - |
View the Top Cash on Hand Companies 
